(1) Manuscripts and figures can be emailed to nyxb_eng@njmu.edu.cn directly. Alternatively,
you can submit your manuscript and a cover letter (that includes your name, address, telephone and fax numbers and e-mail address, with
a mark of 'contribution'), to:
Editorial Department
Journal of Nanjing Medical University
140, Han-Zhong Road, Nanjing
210029, Jiangsu Province, China.
If there are figures, please also send the original figures to us by mail at the above address.
Any original photographs sent to us will not be returned. Receipt of all contributions is acknowledged immediately, with a reference
number for enquiries.
(2) Text, including tables, references and figure legends, should be typed in 12pt with one point
five line-space on one side of A4 (297 210 mm) sheets. Limits on lengths are:
Papers up to 3000 words, abstracts up
to 150 words, up to 20 references
Pay attention to the correct font of capital or small letter, block or italic letter,
Greece letter and other special letters. Marks can be made nearby with pencil if necessary. Please leave your responding telephone number
and postal address. Meanwhile, authors from China should send us a corresponding Chinese manuscript or abstract.
(3) Manuscripts
may not have been published previously or submitted to any other publications. Manuscripts should provide an accompanying statement from
your unit demonstrating that the data collected is correct, that the material has not been submitted to any other publication previously,
and that confidential information has not been betrayed. Unsuitable manuscripts will be rejected after examination.
(4) Please contact
the Editorial Department if after 3 months had no reply you have alerted your submission.
(5) The Editorial Department reserves the
right to make revisions to manuscripts. Discussion with the author is in advance if the revision is against original meanings. Please
indicate to us if you would not want to accept the revision. When manuscripts are returned for improvement, contributors could either
revise according to the comments of the editors or make corresponding explanations. Submit a revised manuscript together with the original
one, to Editorial Department in due time. Lack of resubmission over two months (without any reason) will be regarded as an automatic
withdrawal.
(6) As soon as the article is published, the author is considered to have transferred his rights to the publisher.
Requests for reproduction should be sent to the latter.
(7) All manuscripts accepted will be published in both printed and Electronic
Edition.
(8) Payment will be sent to the author plus two current issues free of charge.
2. Requests for Writing
Basic
Criteria.
Articles should be written in English and meet the following basic criteria: the information is important, the material
is original, the study methods are appropriate, the data are valid, the conclusions are reasonable and supported by the data and the
writing is clear (clinical or laboratory jargon is to be avoided), Original articles should generally be set out under following subheadings: INTRODUCTION, MATERIALS AND METHODS, RESULTS, DISCUSSION, ACKNOWLEDGE AND REFERENCES.
(1) Title. Please be
concise and accurate. If at all possible, subtitles should be avoided. Un-accepted abbreviations and characters, etc. should better
not to be used. A footmark of foundation source should be written at the bottom-left corner of the title page if applicable.
(2) Author and Unit. Only participates in the research project, are to be considered authors. The names (spelled out in full)
of all the authors and their institutions should be listed. Surnames of Chinese authors should be in capital letters as same as the first
letter of first name. For example, Zhigang LI. The institution should be given a full name (including university, department and administrative
office, and the city and the zip code should also be provided.) If a paper has many authors from different units, list letter (a,b,c,et
al)in the top-right corner of authors' name and write down the unit name, city and zip code below each author's name.
(3) Responding
author. A responding author should be designated from one of the authors or the superintendent of this project. Please give
corresponding author details (e-mail address, mailing address, telephone and fax numbers) on the first page.
(4) Abstract.
Abstracts should be structured, with the section headings: Objective: briefly explain the importance of the study topic and state
a precise study question or purpose. Methods: briefly introduce the methods used to perform the study; include information on
the study design, setting, subjects, interventions, outcome measures and analyses as appropriate. Results: briefly present the
significant results, with data and statistical details such as P values where appropriate; be sure that information in the abstract matches
that in the main text. Conclusion: state the meaning of your findings, being careful to address the study question directly and
to confine your conclusions to aspects covered in the abstract; give equal emphasis to positive and negative findings.
(6) Text. Each section of the text can be divided into three subsections at most. Main medicines, reagents, animals
and apparatuses used should be stated clearly, with their sources and specifications. References should be pointed out when adopting
others' methods. The emphasis will be placed on your personal improvement and invention. The content should be accurate and precise.
Word and graphs should not repeat each other.
(7) Abbreviations. Abbreviations should be given a full name when they
are first mentioned in the text or abstract. Afterwards, they could be used directly. Those received abbreviations such as PCR, ECG,
RNA, HIV, may be used in a direct way.
(8) Figures: Figures should be cited consecutively in the body of text based
on 'words first and graphs next'. Full details for the electronic submission of artwork can be obtained from http://www.elsevier.com/authors.
For figures that cannot be submitted electronically, please send them by post to the Editorial Office. All figures should be original
glossy photographs or professional drawings. Please mark the back of each figure with its number and the first author's name, and indicate
the top of the figure. Figures are generally reduced to 84mm wide or less when published. Type the legends below the figures; limit the
legend to 40 words or less. Dyeing methods and enlargement multiples should be indicated for a section graph of tissue.
(9) Tables.
Tables should be a three-line graph and cited consecutively in the text. All numbers should be written in the same decimal pt .Not applicable
data should be represented by a "-". Take care to distinguish between "zero" and "not done" as an entry in the table. Ensure all symbols
or abbreviation are explained.
(8) Drug Names. Use the Recommended International Non-proprietary Name (RINN) for medicinal
substances, unless the specific trade name of a drug is directly relevant to the discussion.
(10) Units. Please use the
metric system for the expression of length, height, weight, mass, area and volume. Temperatures are to be given in degrees Celsius. Please
be better to use Systeme International (SI) units for all hematological and clinical chemistry measurements.
(11) References.
References must be numbered consecutively in order of appearance in the text, and listed in number order in the reference list: do not
alphabetize. Each reference citation within the main body of the text should be a superscript Arabic number (in square brackets). Authors
are responsible for the accuracy and completeness of their references and correct citation in the text. Please pay attention to check
for the content, year, volume, page and so on. Journal titles should be abbreviated in accordance with the Index Medicus. The names of
all the authors when six or fewer, followed by their initials. Otherwise list only the first six and add et al. Please be better
to cite references published within the past five years. Do not cite uncompleted work or work that has not yet been accepted for publication
as references. All references should be presented using the following format:
Journal articles:
[1] Su DH, Chang
YC, Chang CC,Rose Boutros?Post-traumatic anterior and posterior pituitary dysfunction. J Formos Med Assoc 2005; 104:463-7.
[2] Kaplan NM. Coronary heart disease risk factors and antihypertensive drug selection. J Cardiovasc Pharmacol 1982;4(Suppl
2):S187-9.
[3] World Health Organization. Immunoglobulin E: a new class of human immunoglobulin. Bull WHO 1968; 38:151-2.
[4] Adams M, Montague CT, Prins JB, Holder JC, Smith SA, Sanders L, et al. Activators of peroxisome proliferator-activated receptor gamma
have depot-specific effects on human preadipocyte differentiation. J Clin Invest 1997; 100: 3149-53
Books:
[1] Plum F, Posner JB. The Diagnosis of Stupor and Coma, 3rd edition. Philadelphia: FA Davis, 1980:123-33.
[2] Levinsky NG.
Fluid and electrolytes. In: Thorn GW, Adams RD, Braunwald E, et al, eds. Harrison's Principles of Internal Medicine, 8th edition.
New York: McGraw-Hill, 1977:364-75.
